Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL4854960

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
C[C@H]1[C@@H](O[C@@H]2CC[C@]3(C)[C@H]4CC[C@]5(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@H]5[C@@H]4C[C@H](O)[C@@H]3C2)O[C@@H]2O[C@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3

Basic Information

ChEMBL ID CHEMBL4854960
Phase Preclinical
Structure Type MOL
InChI Key ZIINWKOITYBTBX-QFXSOFMZSA-N
16
Targets
16
Activities
1
Assay Types
0
PK Parameters
16
Publications
0
Known Names

Molecular Properties

658.9
MW (Da)
7.71
ALogP
7
HBA
2
HBD
103.7
PSA (Ų)
0.22
QED
2
Ro5 Violations
6
Rot. Bonds

Drug Information

Molecule Type Unknown
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C39H62O8
MW 658.92
Aromatic Rings 0
Heavy Atoms 47
NP-Likeness 2.92

Activity Summary

IC50 16 meas. best 7.52

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
786-0
CHEMBL613102
IC50 7.52 7.52 30.0 1
A549
CHEMBL392
IC50 7.3 7.3 50.0 1
K562
CHEMBL385
IC50 7.05 7.05 90.0 1
NCI-H441
CHEMBL1075542
IC50 6.96 6.96 110.0 1
OV-90
CHEMBL4296481
IC50 6.92 6.92 120.0 1
HCT-116
CHEMBL394
IC50 6.89 6.89 130.0 1
U2OS
CHEMBL615023
IC50 6.57 6.57 270.0 1
RCC4
CHEMBL4483279
IC50 6.5 6.5 320.0 1
HepG2
CHEMBL395
IC50 6.44 6.44 360.0 1
U-87 MG
CHEMBL614247
IC50 6.38 6.38 420.0 1
Kasumi 1
CHEMBL613988
IC50 6.3 6.3 500.0 1
PC-3
CHEMBL390
IC50 6.28 6.28 530.0 1
Jurkat
CHEMBL397
IC50 6.19 6.19 650.0 1
MCF7
CHEMBL387
IC50 5.91 5.91 1220.0 1
RCC4/VHL
CHEMBL4483265
IC50 5.75 5.75 1780.0 1
HeLa
CHEMBL399
IC50 4.66 4.66 22000.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
786-0 IC50 = 30.0 nM 7.52 Anticancer activity against human 786-0 cells assessed as inhibition of cell pro... 34399390
A549 IC50 = 50.0 nM 7.3 Anticancer activity against human A549 cells assessed as inhibition of cell prol... 34399390
K562 IC50 = 90.0 nM 7.05 Anticancer activity against human K562 cells assessed as inhibition of cell prol... 34399390
NCI-H441 IC50 = 110.0 nM 6.96 Anticancer activity against human NCI-H441 cells assessed as inhibition of cell ... 34399390
OV-90 IC50 = 120.0 nM 6.92 Anticancer activity against human OV-90 cells assessed as inhibition of cell pro... 34399390
HCT-116 IC50 = 130.0 nM 6.89 Anticancer activity against human HCT-116 cells assessed as inhibition of cell p... 34399390
U2OS IC50 = 270.0 nM 6.57 Anticancer activity against human U2OS cells assessed as inhibition of cell prol... 34399390
RCC4 IC50 = 320.0 nM 6.5 Anticancer activity against human RCC4 cells assessed as inhibition of cell prol... 34399390
HepG2 IC50 = 360.0 nM 6.44 Anticancer activity against human HepG2 cells assessed as inhibition of cell pro... 34399390
U-87 MG IC50 = 420.0 nM 6.38 Anticancer activity against human U-87 MG cells assessed as inhibition of cell p... 34399390
Kasumi 1 IC50 = 500.0 nM 6.3 Anticancer activity against human Kasumi 1 cells assessed as inhibition of cell ... 34399390
PC-3 IC50 = 530.0 nM 6.28 Anticancer activity against human PC-3 cells assessed as inhibition of cell prol... 34399390
Jurkat IC50 = 650.0 nM 6.19 Anticancer activity against human Jurkat cells assessed as inhibition of cell pr... 34399390
MCF7 IC50 = 1220.0 nM 5.91 Anticancer activity against human MCF7 cells assessed as inhibition of cell prol... 34399390
RCC4/VHL IC50 = 1780.0 nM 5.75 Anticancer activity against human RCC4/VHL cells assessed as inhibition of cell ... 34399390
HeLa IC50 = 22000.0 nM 4.66 Anticancer activity against human HeLa cells assessed as inhibition of cell prol... 34399390

Literature References

Data from ChEMBL 36 via Core Engine